Middle East And Africa Artificial Blood Vessels Market Growth Prospects 2024-2032
Triton Market Research’s report estimates that the Middle East and Africa artificial blood vessels market is set to advance in terms of revenue at a CAGR of 6.48% during the forecast period 2024-2032.
The artificial blood vessels market in the Middle East and Africa is experiencing growth driven by advancements in healthcare infrastructure and government initiatives aimed at improving medical care. Several governments are investing in the development of healthcare systems to address the increasing incidence of cardiovascular diseases, which demand advanced vascular grafts and artificial blood vessels. The UAE, for instance, has been at the forefront of healthcare innovation, supporting initiatives through partnerships between public and private sectors to improve medical technologies and patient care.
The countries mentioned in this region include UAE, Israel, South Africa, Saudi Arabia, and Rest of Middle East & Africa.
Saudi Arabia leads the regional market, reporting around $51.48 million in 2023
Saudi Arabia is strengthening its healthcare capabilities, especially in the production of plasma-derived medicines, which are often crucial in surgeries that involve artificial blood vessels. The involvement of the Public Investment Fund (PIF) in such collaborations reflects a government-backed strategy to expand and enhance medical technologies, facilitating growth in markets such as artificial blood vessels.The rise in cardiovascular diseases has led to increased adoption of artificial grafts and innovations in minimally invasive vascular surgeries. The growing network of hospitals and blood banks further supports the surgical infrastructure necessary for these advanced treatments.Market Forecast for the United Arab Emirates
The artificial blood vessels market in the United Arab Emirates (UAE) is closely linked to the country’s broader commitment to advancing healthcare via innovative technologies. The nation has implemented several initiatives aimed at fostering the growth of medical technologies, including artificial blood vessels. One of the most significant efforts is the Dubai 3D Printing Strategy, which targets the healthcare sector as a key focus. This initiative aims to position Dubai as a global leader in 3D printing by 2030, emphasizing the development of medical products such as artificial organs, bones, and surgical devices. By 2025, the Dubai Health Authority plans to produce 3D-printed artificial limbs at an affordable cost, showcasing the government’s proactive stance in promoting advanced medical solutions.
The market is segmented into type, blood vessel diameter, patient demographic, application, and end-user. The application segment includes hemodialysis, aortic disease, and peripheral artery.
Peripheral artery applications involve using grafts to treat conditions affecting the arteries that supply blood to the legs, arms, and other peripheral areas of the body. The main condition requiring these grafts is peripheral artery disease (PAD), where arteries become narrowed or blocked by plaque buildup (atherosclerosis). In severe cases of PAD, artificial grafts are used in bypass surgeries to redirect blood flow around the blocked artery, restoring circulation to the affected limb.
Contender Analysis in the Artificial Blood Vessels Market:
MedicalExpo is an online platform designed for healthcare professionals and industry stakeholders. It features a comprehensive directory of medical equipment, products, and services from a wide range of manufacturers and suppliers. Offering detailed product descriptions and technical specifications, the platform connects buyers with sellers, simplifying the procurement process and supporting the search for medical solutions.
Other major firms in the market comprise Medtronic Plc, WL Gore and Associates Inc, Getinge AB, and Roumai Medical.